关于Phase 3 Librexia ACS试验的最新进展

投资观察
Nov 20, 2025

11月14日 - 施贵宝公司:*关于Phase 3 Librexia ACS试验的最新进展*施贵宝公司 - 由于疗效问题,Librexia ACS试验已被终止*施贵宝公司 - 对Milvexian未发现新的安全性问题*施贵宝公司 - Librexia AF和中风研究仍在继续,数据预计将在2026年发布

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10